Contraception by Ushercell™ (cellulose sulfate) in formulation: duration of effect and dose effectiveness
Robert A. AndersonDepartment of Obstetrics and Gynecology, Rush University Medical Center, Chicago, IL 60612, USA. [email protected]Kenneth A. FeathergillThe Program for the Topical Prevention of Conception and Disease (TOPCAD), Rush University Medical Center, Chicago, IL 60612, USADiao Xiao-HuiThe Program for the Topical Prevention of Conception and Disease (TOPCAD), Rush University Medical Center, Chicago, IL 60612, USACalvin J. ChanyThe Program for the Topical Prevention of Conception and Disease (TOPCAD), Rush University Medical Center, Chicago, IL 60612, USAWilliam F. RencherCONRAD, Eastern Virginia Medical School, Arlington, VA, 22209, USALourens J.D. ZaneveldThe Program for the Topical Prevention of Conception and Disease (TOPCAD), Rush University Medical Center, Chicago, IL 60612, USADonald P. WallerThe Program for the Topical Prevention of Conception and Disease (TOPCAD), Rush University Medical Center, Chicago, IL 60612, USA
2004en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba